Evidence map›Paper›PMID 35328681›Full record

ArticleInternational journal of molecular sciences2022

NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.

Lola Torz, Kristoffer Niss, Sofia Lundh, Jens C Rekling, Carlos Damian Quintana, Signe Emilie Dannulat Frazier, Aaron J Mercer, Anda Cornea, Charlotte Vinther Bertelsen, Marina Kjærgaard Gerstenberg and 6 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Lola TorzIn Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark.ORCID 0000-0001-6013-3081
Kristoffer NissBioinformatics & Data Mining, Novo Nordisk, 2760 Måløv, Denmark.
Sofia LundhPathology & Imaging, Novo Nordisk, 2760 Måløv, Denmark.ORCID 0000-0002-4552-0312
Jens C ReklingDepartment of Neuroscience, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-8568-2332
Carlos Damian QuintanaCell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark.
Signe Emilie Dannulat FrazierCell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark.ORCID 0000-0002-7391-4773
Aaron J MercerTarget Discovery Platforms, Novo Nordisk, Seattle, WA 98109, USA.ORCID 0000-0002-9586-6610
Anda CorneaTarget Discovery Platforms, Novo Nordisk, Seattle, WA 98109, USA.
Charlotte Vinther BertelsenCell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark.
Marina Kjærgaard GerstenbergGOLD In Vivo Pharmacology DK I, Novo Nordisk, 2760 Måløv, Denmark.
Ann Maria Kruse HansenIn Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark.
Mette GuldbrandtIn Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark.
Jens LykkesfeldtSection for Experimental Animal Models, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg, Denmark.ORCID 0000-0002-6514-8407
Linu Mary JohnGOLD In Vivo Pharmacology DK I, Novo Nordisk, 2760 Måløv, Denmark.
J Carlos VillaescusaCell Therapy R&D, Novo Nordisk, 2760 Måløv, Denmark.
Natalia PetersenIn Vitro Obeisty Research, Novo Nordisk, 2760 Måløv, Denmark.
Novo Nordisk (Denmark) · DKUniversity of Copenhagen · DKTarget (United States) · US

Funding

LifePharm Centre for In Vivo Pharmacology 1001109652
6 · The paper itself

Abstract

Restoring the control of food intake is the key to obesity management and prevention. The arcuate nucleus (ARC) of the hypothalamus is extensively being studied as a potential anti-obesity target. Animal studies showed that neuropeptide FF (NPFF) reduces food intake by its action in neuropeptide Y (NPY) neurons of the hypothalamic ARC, but the detailed mode of action observed in human neurons is missing, due to the lack of a human-neuron-based model for pharmacology testing. Here, we validated and utilized a human-neural-stem-cell-based (hNSC) model of ARC to test the effects of NPFF on cellular pathways and neuronal activity. We found that in the human neurons, decreased cAMP levels by NPFF resulted in a reduced rate of cytoplasmic calcium oscillations, indicating an inhibition of ARC NPY neurons. This suggests the therapeutic potential of NPFFR2 in obesity. In addition, we demonstrate the use of human-stem-cell-derived neurons in pharmacological applications and the potential of this model to address functional aspects of human hypothalamic neurons.

Indexed as

Neuropeptide YOligopeptidesAnimalsArcuate Nucleus of HypothalamusHumansNeuronsObesityNeuropeptide YOligopeptidesphenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamideappetite controlhuman-arcuate-like neuronsneuropeptide FFneuropeptide FF receptor 2obesityscreening platform

Identifiers

PMID35328681
PMCPMC8948797
OpenAlexW4221104696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.